| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcffd385b763387b8bc29b364cdd0f54 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1477 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B90-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-12 |
| filingDate |
2022-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ef2856a02385cc7d36588e8be524ce8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d361ae3cec15b50dab366b3e153d4a99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_982d5e81fa47c3f7bf59c4d61aa016da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab049f7390b69bb40e9cee91de484a6 |
| publicationDate |
2022-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022362549-A1 |
| titleOfInvention |
Selective modulation of intracellular effects of cells using pulsed electric fields |
| abstract |
A system and method for selectively treating aberrant cells such as cancer cells through administration of a train of electrical pulses is described. The pulse length and delay between successive pulses is optimized to produce effects on intracellular membrane potentials. Therapies based on the system and method produce two treatment zones: an ablation zone surrounding the electrodes within which aberrant cells are non-selectively killed and a selective treatment zone surrounding the ablation zone within which target cells are selectively killed through effects on intracellular membrane potentials. As a result, infiltrating tumor cells within a tumor margin can be effectively treated while sparing healthy tissue. The system and method are useful for treating various cancers in which solid tumors form and have a chance of recurrence from microscopic disease surrounding the tumor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707629-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11655466-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737810-B2 |
| priorityDate |
2014-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |